Would you give EP chemotherapy to a patient with Stage IIA nonseminoma with negative markers who underwent RPLND and had pN2 disease with predominant teratoma?   

Would you think differently about chemotherapy based on %teratoma or size of lymph nodes vs number of lymph nodes (eg. multiple small LN vs single 2-5cm mass)?

Answer from: Medical Oncologist at Community Practice